Quadlytics Raises JPY 600 Million in Series A to Advance the Epileptic Seizure Prediction System
Summary
Quadlytics raised JPY 300 million in Series A equity funding and secured up to JPY 300 million in grant support, bringing the total round to JPY 600 million. The Kyoto-based digital health company is building a software-based medical device that uses a wearable ECG device and machine-learning anomaly detection to predict epileptic seizures in real time. The company is pursuing regulatory approval in Australia first, with plans to launch there by 2028 and expand to the United States by 2030. It has also joined accelerator and research programs with MedTech Actuator and Mayo Clinic to support clinical validation and market entry.
Funding
Amount
$2.1M
Total raised
Date
May 30, 2025
Announcement date
Investors
Lifetime Ventures, New Energy and Industrial Technology Development Organization, MedTech Actuator, XTech Ventures
Lead investors
Company
https://www.quadlytics.com/
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected